ClinicalIntelPulse · Clinical Deal Signal Lite

import { wrapFetchWithPayment } from "@x402/fetch";
import { privateKeyToAccount } from "viem/accounts";

const account = privateKeyToAccount(process.env.PRIVATE_KEY);
const fetchWithPay = wrapFetchWithPayment(fetch, account);

const res = await fetchWithPay("https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal-lite", {
  method: "GET",
});
const data = await res.json();

curl -X GET \
  "https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal-lite?condition=Disease+area+%E2%80%94+e.g.+%22Obesity%22+%7C+%22Cardiovascular%22+%7C+%22Oncology%22+%7C+%22Rare+Neurological%22+%7C+%22Autoimmune%22&stage=phase2+%7C+phase3+%7C+both+%28default%3A+both%29" \
  -H "X-PAYMENT: <signed x402 payment>"

{
  "candidate_assets": [
    {
      "nctId": "NCT05564117",
      "phase": "PHASE3",
      "sponsor": "Innovent Biologics",
      "status": "ACTIVE_NOT_RECRUITING",
      "title": "Mazdutide in Obesity"
    }
  ],
  "deterministic": true,
  "industry_sponsored": {
    "phase2_count": 51,
    "phase3_count": 15,
    "total": 66
  },
  "pipeline_totals": {
    "phase2_count": 62,
    "phase3_count": 18,
    "total_active": 80
  },
  "query_summary": {
    "as_of": "2026-07-25",
    "condition": "Obesity",
    "stage": "both"
  },
  "sponsor_breakdown": [
    {
      "sponsor": "Novo Nordisk A/S",
      "trial_count": 8
    }
  ],
  "upsell": {
    "adds": "Acquisition rationale per asset, recent deal comps with dollar values, estimated deal-value ranges, likely acquirers, deal-timing signals.",
    "full_product": "/api/clinical/deal-signal",
    "price_usd": 0.35
  }
}